[HTML][HTML] TOX expression in mycosis fungoides and sezary syndrome

A Pileri, M Cavicchi, C Bertuzzi, S Righi, C Zengarini… - Diagnostics, 2022 - mdpi.com
Mycosis fungoides (MF) and Sezary syndrome (SS) are the two most common type of
cutaneous T-cell lymphoma (CTCL). Currently, no markers can be clearly related to …

Genetic predisposition to early mycosis fungoides: investigating genetic polymorphisms in tissue-resident memory T-cell genes

N Almaani, F Farhan, S Bani Hamad… - Journal of …, 2024 - journals.sagepub.com
Objectives Mycosis fungoides (MF) is the most common cutaneous T-cell lymphoma; it
arises from tissue-resident memory T-cells (TRM). In the present study, we investigated …

TOX, TWIST1, STAT4, and SATB1 protein expressions in early‐stage mycosis fungoides

S Örnek, S Ozekinci, T Ipin… - Journal of Cutaneous …, 2024 - Wiley Online Library
Background Diagnosis of early mycosis fungoides (eMF) is challenging and often delayed
as many of its clinical and histopathologic features may mimic various benign inflammatory …

Novel Biomarkers in Cutaneous T Cell Lymphomas

GK Przybylski - 2022 - preprints.org
Cutaneous T cell lymphomas (CTCLs) are caused by malignant clonal proliferation of skin-
tropic T cells. Most patients have an indolent disease course managed with skin-directed …

Validity of Immunohistochemical Expression of Cell Adhesion Molecule 1 (CADM1) in Differentiating Early-Stage Mycosis Fungoides from Its Benign Mimickers.

AM Elshabrawy, MA Gobran, NF Elaidy… - Egyptian Journal of …, 2023 - ejhm.journals.ekb.eg
Background: Mycosis fungoides (MF) is the commonest cutaneous T-cell lymphoma. Early-
stage MF is difficult to be differentiated from benign inflammatory dermatoses (BIDs) …

[PDF][PDF] Role of Immunohistochemistry in Differentiating Early-Stage Mycosis Fungoides from Its Benign Mimickers

AM Elshabrawy, MA Gobran, NF Elaidy… - …, 2022 - researchgate.net
Mycosis fungoides (MF) is the most common type of cutaneous T-cell lymphomas (CTCLs),
which accounts for over 50% of all CTCL cases. The clinical course of MF is defined by the …